Table 4:
Patient-Reported Outcomes
| PROs | Assessmentα  | Baseline (n=56) | Post-RT (n=51) | 3 month (n=44) | 12 month (n=35) |
|---|---|---|---|---|---|
| Quality of Lifeα | 8–10 | 95% | 96% | 89% | 91% |
| 4–7 | 4% | 2% | 7% | 9% | |
| 1–3 | 1% | 2% | 4% | 0% | |
| Breast Cosmesis€ | Excellent | 55% | 41% | 50% | 69% |
| Good | 45% | 49% | 39% | 26% | |
| Fair | 0% | 10% | 9% | 6% | |
| Poor | 0% | 0% | 2% | 0% | |
| Painβ | 0–3 | 61% | 69% | 86% | 86% |
| 4–6 | 32% | 22% | 7% | 9% | |
| 7–10 | 7% | 10% | 7% | 6% | |
| Fatigueβ | 0–3 | 61% | 55% | 75% | 71% |
| 4–6 | 25% | 37% | 16% | 12% | |
| 7–10 | 14% | 8% | 9% | 17% | |
| Skin Burns‡ | None | 100% | 90% | 88% | 100% |
| Mild | 0% | 8% | 12% | 0% | |
| Moderate | 0% | 0% | 0% | 0% | |
| Severe | 0% | 0% | 0% | 0% | |
| Very Severe | 0% | 2% | 0% | 0% |
α
LASA: Reported on a scale of 1–10 (1 indicating “as bad as it can be” and 10 indicating “as good as it can be”)
β
LASA: Reported on a scale of 0–10 (0 indicating “none” and 10 indicating “as bad as it can be”)
€
HBCS: Reported on a 4-point scale (excellent, good, fair, poor)
‡
PRO-CTCAE: Reported on a 5-point scale (none, mild, moderate, severe, very severe)